Sr. Director, Analytical GMP Testing Capabilities at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Collaborative, inclusive, and visionary leadership qualities
Expertise in shaping and leading centralized GMP testing strategies and operations within Product Research and Development (PRD)
Ability to work cross-functionally and in close partnership with initiatives like the Lilly Medicine Foundry
Strong focus on safety, regulatory compliance, and inspection readiness
Capability to integrate emerging technologies, new scientific insights, and evolving regulatory requirements

Responsibilities

Define and implement GMP testing capabilities for clinical trial materials, ensuring alignment with PRD strategy and strategic investments such as the Medicine Foundry
Collaborate across PRD to deliver testing solutions that support a diverse and evolving portfolio of biological and synthetic modalities
Lead continuous improvement efforts and drive an integrated GMP testing strategy
Oversee laboratory operations with a strong focus on safety, regulatory compliance, and inspection readiness
Maintain a safe, compliant work environment by ensuring adherence to all applicable regulations
Integrate emerging technologies, new scientific insights, and evolving regulatory requirements into team practices and decision-making
Foster a high-performance team culture through coaching, mentoring, performance management, and career development; contribute to talent assessment and succession planning
Deliver testing capabilities that are both flexible and reliable, meeting the speed and quality expectations of a dynamic clinical development portfolio

Skills

GMP Testing

Analytical Testing

CMC Development

Pharmaceutical Manufacturing

Drug Development

Quality Control

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free